EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model

Olivier René iD, Manuel Saldivia, Maxime Dauphinais, Lei Zhang iD, Scott A Hollingsworth iD, Jan Jiricek, Dennis C Koester iD, Sarah L Miller, Sarah L Williams, Pearly S Ng iD, Debjani Patra, Rajiv S Jumani und 10 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c02459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Olivier René und 21 weiteren Autor:innen. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Trypanocidal Agents, Triazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Innovation in 3Rs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas Disease is a neglected tropical disease caused by the parasite Trypanosoma cruzi, affecting millions worldwide. Current treatments suffer from variable efficacy, long duration, and safety concerns, highlighting the need for better therapies. A phenotypic screening of the Novartis compound library against Trypanosoma brucei identified cyanotriazole (CT) compounds with rapid sterilizing activity across kinetoplastids via selective inhibition of parasite topoisomerase II. First-generation CTs had safety liabilities, including lymphopenia and neutrophilia due to sphingolipid pathway modulation. Medicinal chemistry optimization led to a tailored aminopyrrolidine core structure for Chagas Disease, improving ADME properties and reducing off-target effects. IID432 showed potent activity against T. cruzi (EC50 = 8 nM) and achieved a relapse-free cure in a chronic mouse model of infection with shorter treatment duration. These findings support IID432 as a promising fast-acting, curative therapy for T. cruzi infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma cruziChagas DiseaseTrypanocidal AgentsTriazolesTopoisomerase II InhibitorsDNA Topoisomerases, Type IIAnimalsMiceStructure-Activity RelationshipHumansDisease Models, AnimalDrug DiscoveryChronic Disease

Substanzen

Trypanocidal AgentsTriazolesTopoisomerase II InhibitorsDNA Topoisomerases, Type II

Autor:innen und Institutionen

ORCID-Profile: Olivier René, Lei Zhang, Scott A Hollingsworth, Dennis C Koester, Pearly S Ng, Srinivasa P S Rao

Förderung

  • Wellcome Trust
  • Innovation in 3Rs

Zitieren

APA

René, O., Saldivia, M., Dauphinais, M., Zhang, L., Hollingsworth, S. A., Jiricek, J., Koester, D. C., Miller, S. L., Williams, S. L., Ng, P. S., Patra, D., Jumani, R. S., Baxley, G. M., Osborne, C. S., Chen, Y. B., Chen, Y. L., Cheung, H., Lakshminarayana, S. B., Galarneau, J. R., …, & Rao, S. P. S. (2026). Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02459

Vancouver

René O, Saldivia M, Dauphinais M, Zhang L, Hollingsworth SA, Jiricek J, et al. Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02459

BibTeX
@article{Ren2026,
  author = {René, Olivier and Saldivia, Manuel and Dauphinais, Maxime and Zhang, Lei and Hollingsworth, Scott A and Jiricek, Jan and Koester, Dennis C and Miller, Sarah L and Williams, Sarah L and Ng, Pearly S and Patra, Debjani and Jumani, Rajiv S and Baxley, Grace M and Osborne, Colin S and Chen, Ying-Bo and Chen, Yen-Liang and Cheung, Harry and Lakshminarayana, Suresh B and Galarneau, Jean-René and Diagana, Thierry T and Sarko, Christopher and Rao, Srinivasa P S},
  title = {Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c02459}
}
Kostenlos starten →